A detailed history of National Bank Of Canada transactions in Exact Sciences Corp stock. As of the latest transaction made, National Bank Of Canada holds 780 shares of EXAS stock, worth $46,878. This represents 0.0% of its overall portfolio holdings.

Number of Shares
780
Previous 780 -0.0%
Holding current value
$46,878
Previous $53,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$42.43 - $70.83 $381 - $637
-9 Reduced 1.14%
780 $53,000
Q2 2024

Aug 02, 2024

BUY
$41.33 - $74.26 $909 - $1,633
22 Added 2.87%
789 $33,000
Q1 2024

May 13, 2024

SELL
$56.27 - $73.77 $4,557 - $5,975
-81 Reduced 9.55%
767 $52,000
Q4 2023

Feb 06, 2024

BUY
$59.06 - $75.72 $11,812 - $15,144
200 Added 30.86%
848 $62,000
Q3 2023

Oct 10, 2023

SELL
$65.94 - $99.04 $1,978 - $2,971
-30 Reduced 4.42%
648 $44,000
Q2 2023

Jul 26, 2023

BUY
$62.68 - $95.05 $22,000 - $33,362
351 Added 107.34%
678 $63,000
Q1 2023

Apr 12, 2023

BUY
$47.19 - $70.77 $1,274 - $1,910
27 Added 9.0%
327 $22,000
Q4 2022

Jan 24, 2023

SELL
$30.35 - $53.15 $26,981 - $47,250
-889 Reduced 74.77%
300 $0
Q3 2022

Oct 13, 2022

BUY
$31.97 - $49.37 $15,985 - $24,685
500 Added 72.57%
1,189 $39,000
Q2 2022

Jul 28, 2022

SELL
$35.61 - $76.23 $8,582 - $18,371
-241 Reduced 25.91%
689 $27,000
Q1 2022

May 05, 2022

SELL
$57.56 - $82.54 $623,259 - $893,743
-10,828 Reduced 92.09%
930 $65,000
Q4 2021

Jan 24, 2022

BUY
$72.5 - $100.68 $852,455 - $1.18 Million
11,758 New
11,758 $940,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.6B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.